Bayer Pharma Aktiengesellschaft v Generic Health Pty Ltd (No 2)

Afectaciones

CITA

• Aktiebolaget Hässle v Alphapharm Pty Ltd
• Aktiebolaget Hassle v Alphapharm Pty Ltd
• Alphapharm Pty Ltd v H Lundbeck A/S (No 2)

[ver más]

• Bayer Pharma Aktiengesellschaft v Generic Health Pty Ltd
• Cancer Voices Australia v Myriad Genetics Inc.
• Doric Products Pty Ltd v Lockwood Security Products Pty Ltd
• National Research Development Corporation v Commissioner of Patents
• Olin Mathieson Chemical Corporation v Biorex Laboratories Ltd
• Populin v Hb Nominees Pty Ltd
• Eli Lilly and Company v Pfizer Overseas Pharmaceuticals
• Wellcome Foundation Ltd v Vr Laboratories (Aust) Pty Ltd

REPORTED OPINION OF por

• [2013] FCA 279

Documentos citados

• Aktiebolaget Hässle v Alphapharm Pty Ltd
• Doric Products Pty Ltd v Lockwood Security Products Pty Ltd
• Populin v Hb Nominees Pty Ltd
• Alphapharm Pty Ltd v H Lundbeck A/S (No 2)
• Eli Lilly and Company v Pfizer Overseas Pharmaceuticals



Ver todas las citas

• Olin Mathieson Chemical Corporation v Biorex Laboratories Ltd
• Wellcome Foundation Ltd v Vr Laboratories (Aust) Pty Ltd
• National Research Development Corporation v Commissioner of Patents
• Bayer Pharma Aktiengesellschaft v Generic Health Pty Ltd
• Aktiebolaget Hassle v Alphapharm Pty Ltd
• Cancer Voices Australia v Myriad Genetics Inc.